Beleave Inc (CSE: BE) has replaced Jeanette VanderMarel as CEO of the firm. Taking her place will be that of Kevin Keagan, who joined the firm in late 2018 and was previously the interim chief financial officer for the firm. VanderMarel will be staying on with the firm as a director, following her appointment earlier this month.
Following the announcement of Keagan being named the new chief executive of the firm, Beleave released news indicating that they have received a purchase order to the tune of $2.7 million for their second generation cannabis products. Additionally, the firm will be launching a new brand for the second generation products, to be known as Compliance Brand. The brand is expected to launch a face serum, a bath oil and a multi use balm all of which will be infused with THC.
I look forward to continuing to realize the benefits of our efforts, announcing new products and strategies, and evolving to grow our business in this exciting time. Canadians are increasingly looking for new and safe ways to consume cannabis, and our investments in Cannabis 2.0 products allows us to meet that demand, while maintaining strict protocols and introducing higher-margin, standardized products – strengthening our bottom line.
Kevin Keagan, CEO of Beleave Inc.
The departure of VanderMarel from Beleave was highly public, with VanderMarel announcing the management change yesterday via Twitter prior to the company making an official announcement on the matter. She was in the role for approximately 9 weeks prior to her departure.
Beleave Inc last traded at $0.025 on the CSE, up 25% on the day.
Information for this briefing was found via Sedar and Beleave Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
